BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, they discovered that BC-CML-initiating cells had higher levels of BCAT1 mRNA, and that transduction of shRNA targeting BCAT1 mRNA reduced intracellular BCAA levels, which impeded the ability to form colonies in vitro.